You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
The ID Now COVID-19 test is the second assay from the company to receive EUA from the FDA, following the same designation issued to the Abbott RealTime SARS CoV-2.
The NxTag CoV Extended Panel is a multiplex PCR test that uses the company's bead-based NxTag technology to detect coronavirus in nasopharyngeal swab specimens.
The $2.2 trillion economic stimulus package, aimed at bolstering the economy against the effects of the SARS-CoV-2 pandemic, has been signed into law by President Trump.
The alliance, led by Singapore-based startup Proteona, also includes several organizations from that city state as well as German research institutes.
News items for the week of March 23, 2020.
FIND will use the funding to support the development of rapid tests, especially in low- and middle-income countries.
A sequencing analysis led by researchers at Shantou University in China provides evidence that pangolins may be an intermediary host for SARS-CoV-2.
Sysmex anticipates delivering the kit to Japanese medical institutions this month for diagnosis of the SARS-CoV-2 infection.
The BGI Real-Time Fluorescent RT-PCR Kit for detecting SARS-2019-nCoV runs in approximately three hours and can be manufactured in large volumes, the firm has said.
Master's and doctoral students in the UK call on funding groups to extend their grants for the duration of the disruption caused by the COVID-19 outbreak, the Guardian reports.
Squid can make edits to their RNA within the cytoplasm of their axons, Science News reports.
The Chan Zuckerberg Initiative is putting $25 million toward COVID-19 treatment research, according to the Verge.
In Science this week: researchers engineer version of Cas9 that is nearly PAM-less, and more.